A Subset of Arabidopsis AP2 Transcription Factors Mediates Cytokinin Responses in Concert with a Two-Component Pathway by Rashotte, Aaron M et al.
Dartmouth College
Dartmouth Digital Commons
Open Dartmouth: Faculty Open Access Articles
7-18-2006
A Subset of Arabidopsis AP2 Transcription Factors
Mediates Cytokinin Responses in Concert with a
Two-Component Pathway
Aaron M. Rashotte




University of North Carolina at Chapel Hill
Fernando J. Ferreira
University of North Carolina at Chapel Hill
G. Eric Schaller
Dartmouth College
See next page for additional authors
Follow this and additional works at: https://digitalcommons.dartmouth.edu/facoa
Part of the Biology Commons, Genetics Commons, Physiology Commons, and the Plant
Sciences Commons
This Article is brought to you for free and open access by Dartmouth Digital Commons. It has been accepted for inclusion in Open Dartmouth: Faculty
Open Access Articles by an authorized administrator of Dartmouth Digital Commons. For more information, please contact
dartmouthdigitalcommons@groups.dartmouth.edu.
Recommended Citation
Rashotte, Aaron M.; Mason, Michael G.; Hutchison, Claire E.; Ferreira, Fernando J.; Schaller, G. Eric; and Kieber, Joseph J., "A Subset
of Arabidopsis AP2 Transcription Factors Mediates Cytokinin Responses in Concert with a Two-Component Pathway" (2006). Open
Dartmouth: Faculty Open Access Articles. 1403.
https://digitalcommons.dartmouth.edu/facoa/1403
Authors
Aaron M. Rashotte, Michael G. Mason, Claire E. Hutchison, Fernando J. Ferreira, G. Eric Schaller, and Joseph
J. Kieber
This article is available at Dartmouth Digital Commons: https://digitalcommons.dartmouth.edu/facoa/1403
A subset of Arabidopsis AP2 transcription factors
mediates cytokinin responses in concert with
a two-component pathway
Aaron M. Rashotte*, Michael G. Mason†, Claire E. Hutchison*, Fernando J. Ferreira*, G. Eric Schaller†,
and Joseph J. Kieber*‡
*Department of Biology, University of North Carolina, Chapel Hill, NC 27599-3280; and †Department of Biological Sciences, Dartmouth College,
Hanover, NH 03755
Edited by Maarten Koornneef, Wageningen University and Research Centre, Wageningen, Netherlands, and approved June 1, 2006 (received for review
March 13, 2006)
The plant hormone cytokinin regulates numerous growth and
developmental processes. A signal transduction pathway for cy-
tokinin has been elucidated that is similar to bacterial two-
component phosphorelays. In Arabidopsis, this pathway is com-
prised of receptors that are similar to sensor histidine kinases,
histidine-containing phosphotransfer proteins, and response reg-
ulators (ARRs). There are two classes of response regulators, the
type-A ARRs, which act as negative regulators of cytokinin re-
sponses, and the type-B ARRs, which are transcription factors that
play a positive role in mediating cytokinin-regulated gene expres-
sion. Here we show that several closely related members of the
Arabidopsis AP2 gene family of unknown function are transcrip-
tionally up-regulated by cytokinin through this pathway, and we
have designated these AP2 genes CYTOKININ RESPONSE FACTORS
(CRFs). In addition to their transcriptional regulation by cytokinin,
the CRF proteins rapidly accumulate in the nucleus in response to
cytokinin, and this relocalization depends on the histidine kinases
and the downstream histidine-containing phosphotransfer pro-
teins, but is independent of the ARRs. Analysis of loss-of-function
mutations reveals that the CRFs function redundantly to regulate
the development of embryos, cotyledons, and leaves. Furthermore,
the CRFs mediate a large fraction of the transcriptional response to
cytokinin, affecting a set of cytokinin-responsive genes that largely
overlaps with type-B ARR targets. These results indicate that the
CRF proteins function in tandem with the type-B ARRs to mediate
the initial cytokinin response. Thus, the evolutionarily ancient
two-component system that is used by cytokinin branches to
incorporate a unique family of plant-specific transcription factors.
cell signaling  plant hormones
Cytokinins are N6 substituted adenine derivatives that werefirst identified by their ability to promote division in cultured
plant cells together with a second hormone, auxin (1). Cytoki-
nins have since been shown to play a role in diverse aspects of
plant growth and development, including cell division, shoot
initiation, apical meristem function, and vascular formation (2,
3). Recently, remarkable progress has been made in our under-
standing of cytokinin biosynthesis, metabolism, and perception.
The genes encoding the key biosynthetic enzymes have been
identified in plants, as have genes encoding several important
cytokinin metabolic enzymes (4). A model for cytokinin per-
ception and signaling has emerged that is similar to bacterial
two-component phosphorelays (5). Binding of cytokinins to the
Arabidopsis sensor histidine kinases (AHKs) initiates a phos-
phorelay in which the Arabidopsis histidine-containing phospho-
transfer proteins (AHPs) are phosphorylated and then translo-
cate into the nucleus where they likely transfer the phosphate to
the Arabidopsis type-B response regulators (ARRs) (6–10). The
type-B ARRs play a role in meditating the transcriptional
response to cytokinin, including the induction of a second class
of response regulators called the type-A ARRs (6, 11). The
type-A ARRs are cytokinin primary response genes that act as
highly redundant negative regulators of the primary signal
transduction pathway (12–14). The pseudophosphotransfer pro-
tein AHP6 also acts as a negative regulator of cytokinin signal-
ing, and plays a role in vascular development (15).
Gene expression in response to cytokinin has been extensively
studied, and numerous genes have been identified that are
transcriptionally up-regulated in response to cytokinin (16–18)
including two members of the AP2ERF superfamily of tran-
scription factors within the ethylene response factor (ERF)
family (17). Here, we demonstrate that this subgroup of AP2
transcription factors moves into the nucleus in response to
cytokinin, and that they mediate, together with the type-B
ARRs, the transcriptional response to cytokinin.
Results and Discussion
The CRF Genes Are Transcriptionally Induced by Cytokinin in a Type-B
ARR-Dependent Manner. The ERF family is comprised of 65
genes (19), several of which have been implicated in the
response to the plant hormones ethylene, jasmonic acid, and
cytokinin (20–22). Phylogenetic analysis of the predicted
ERF-like proteins places the two cytokinin up-regulated genes
in a subclade of six previously uncharacterized genes that fall
into three pairs based on sequence similarity (Fig. 1B; see Figs.
5 and 6, which are published as supporting information on the
PNAS web site). We named these six genes CYTOKININ
RESPONSE FACTORS (CRFs) to ref lect their similarity to
ERFs and the observation that some members are transcrip-
tionally up-regulated by cytokinin.
We examined the expression of the CRF genes in response to
cytokinin by northern analysis. Consistent with previously re-
ported microarray data (see Table 2, which is published as
supporting information on the PNAS web site), the CRF2 and
CRF5 transcripts are up-regulated 2- to 4-fold by cytokinin (Fig.
1A). The induction of both genes is rapid (30 min), although
CRF2 expression peaks at 60 min and then begins to decline,
whereas induction of CRF5 is more sustained. CRF6 expression
is also up-regulated by cytokinin, but more slowly. In contrast,
the transcript levels of CRF1, CRF3, and CRF4 show little or no
change in response to cytokinin (Fig. 1A and Table 2). The
induction ofCRF2 andCRF5 by cytokinin depends on the type-B
ARRs, as an arr1,12 double mutant (23) severely reduces the
response of these genes to cytokinin (Fig. 1C). Examination of
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the 5 region of the CRF2 and CRF5 genes reveals the presence
of multiple type-B consensus binding sites (17, 24), consistent
with these CRFs being direct targets of type-B ARRs.
CRF Proteins Rapidly Relocalize to the Nucleus in Response to Cyto-
kinin.To explore the subcellular localization of the CRF proteins,
we examined protoplasts transformed with GFP:CRF fusions
expressed from the caulif lower mosaic (CaMV) 35S promoter.
In the absence of cytokinin, we observed relatively uniform
fluorescence throughout the cell. After treatment with cytoki-
nin, all six GFP:CRF fusion proteins accumulated in the nucleus
(Fig. 2A; see Fig. 7, which is published as supporting information
on the PNAS web site). This nuclear accumulation was never
observed in protoplasts treated with a DMSO vehicle control.
Nuclear accumulation in response to cytokinin was observed in
50% of the transformed protoplasts and was very was rapid,
occurring within 5–10 min, which is consistent with a relocation
of preexisting protein. Additionally, this characteristic is inde-
pendent of transcriptional induction, as these CRF fusions were
driven by the constitutive CaMV 35S promoter. Cytokinin-
induced nuclear accumulation is not a general property of ERF
transcription factors, as two other ERFs that cluster outside of
the CRF subgroup display constitutive nuclear localization (25).
The rapid cytokinin-induced intracellular relocalization of CRFs
was also observed in wild-type Arabidopsis stably transformed
with CRF2:GFP, CRF5:GFP, or CRF6:GFP translation fusions
expressed from their native promoters (Fig. 2C; data not shown).
This relocalization was observed in the majority of the root hair
cells that were examined, and occurred in multiple other cell
types as well (data not shown). Consistent with the rapid kinetics,
treatment with cycloheximide (an inhibitor of protein synthesis)
did not inhibit nuclear accumulation of CRF5:GFP in seedlings
(Fig. 2C) or in protoplasts (data not shown), indicating that
preexisting CRF protein moves into the nucleus.
CRF Protein Relocalization Defines a Branch Point in the Cytokinin
Phosphorelay Response Pathway. We examined the role of two-
component elements in the cytokinin-induced nuclear accumu-
lation of the CRFs. To this end, CaMV 35S:GFP:CRF2 con-
structs were transformed into protoplasts derived from cytokinin
signaling mutants. In homozygous double ahk3,4 and triple
ahk2,3,4 receptor mutant protoplasts, the distribution of the
fluorescence signal from the GFP:CRF2 fusion protein was not
altered by the addition of cytokinin (Fig. 2B), indicating that
cytokinin-mediated nuclear accumulation of the CRFs requires
the cytokinin AHK receptors. The histidine kinase inhibitor
3,3,4,5-tetrachlorosalicylanilide (TCSA) also blocked the
movement of 35S:GFP:CRF2 in response to cytokinin (Fig. 2B),
indicating that the histidine kinase activity of the cytokinin
receptors is required for relocalization.
Functioning immediately downstream of the cytokinin recep-
tors are the AHPs, which like the CRFs, also exhibit cytokinin-
dependent nuclear localization (6). As with the receptor triple
mutants, no nuclear accumulation of GFP:CRF2 was observed
in response to cytokinin in transformed ahp1,2,3,4,5 protoplasts
(C.E.H. and J.J.K., unpublished data) (Fig. 2B). In contrast,
disruption of multiple type-B ARRs (i.e., the arr1,2,10,12 mu-
tant) did not affect CRF nuclear movement in response to
cytokinin (Fig. 2B). This is unlikely a result of residual cytokinin
responsiveness as the arr1,2,10,12 mutant is more insensitive to
cytokinin in a variety of cytokinin response assays (data not
shown) than is the ahk3,4 double mutant, which blocks the CRF
nuclear accumulation. Likewise, disruption of multiple type-A
ARRs (arr3,4,5,6,8,9) did not alter the distribution of the CRF
proteins (Fig. 2B). Thus, both the AHPs and cytokinin receptors
are required for the cytokinin-regulated movement of CRFs into
the nucleus, but the downstream ARRs are not.
Fig. 1. Induction ofCRFgenes by cytokinin. (A) Levels ofCRF transcripts after
cytokinin treatment were examined by using Northern blot analysis. (B) An
unrooted phylogenic tree of the 65 ERF predicted proteins. Representative
proteins are indicated; for a full list, see Fig. 5. The CRFs comprise a distinct
subfamily with the cytokinin inducible members indicated by an asterisk. (C)
Cytokinin induction of CRF transcripts requires type-B ARRs. Real-time PCR of
CRF2andCRF5 confirm that they are induced after cytokinin treatment (10M
BA) for 1 h relative to a DMSO control in wild type, but are not induced in the
type-B mutant arr1,12.
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The CRFs Play a Role in the Development of Cotyledons, Leaves, and
Embryos. To determine the physiological role of the CRF genes,
we characterized plants containing single and multiple loss-of-
function CRF mutations (see Fig. 8, which is published as
supporting information on the PNAS web site). Single crf
mutants showed minor, poorly penetrant defects in cotyledon
development (3–5%; Fig. 3A; see Table 3, which is published as
supporting information on the PNAS web site). In all single CRF
mutant alleles identified, small notches appear in the cotyledons
and occasionally the first true leaves, suggesting localized areas
of restricted cell expansion or division. The penetrance of the
phenotype increased when seedlings were grown at elevated
temperatures (data not shown), as has been observed in the
asymmetric leaves (as1 and as2) and cup-shaped cotyledons (cuc1
and cuc2) mutants (26, 27). In multiple crf mutants, the pen-
etrance of the phenotype increases, reaching up to 50% in the
crf1,2,5 triple mutant. These results indicate genetic redundancy
among the CRFs. The severity of the phenotype also increases
as more genes are disrupted (Fig. 3A). Cotyledon development
in the triple crf1,2,5 mutant is severely affected, forming coty-
ledons that are greatly reduced in size and translucent or white
in color. This reduced cotyledon size is primarily the result of
reduced cell expansion, as the area of severely affected cotyle-
dons was reduced by almost 96%, but epidermal cell number was
reduced only 30% (wild type 27.7  1.9 mm2 and 996  103
Fig. 2. CRF proteins accumulate in the nucleus in response to cytokinin. (A)
CaMV 35S:GFP:CRF constructs were transformed into wild-type protoplasts and
examined by using epifluorescent microscopy after treatment with cytokinin or
DMSO control as indicated for 5–10 min. (B) CRF protein nuclear localization
requires the AHKs and AHPs. A 35S:GFP:CRF2 construct was transformed and
examined following cytokinin treatment in protoplasts from wild type, ahk3,4,
ahk2,3,4, ahp1,2,3,4,5, arr1,2,10,12, or arr3,4,5,6,8,9 leaves. Additionally, wild-
type protoplasts were treated with 10 mM of the histidine kinase inhibitor TCSA
for 30 min before treatment. (C) Visualization of CRF5:GFP in root hair cell of a
transgenic plant harboring a genomic CRF5 fragment fused to GFP. Seedlings
were examined after cytokinin treatment as in A.
Fig. 3. Phenotypes of crf loss-of-function mutations. (A) Representative
whole seedlings and a close-up of cotyledons. CRF mutant cotyledon defects
increase in severity from a notch in the single mutants to an extreme lack of
cell expansion of the triple mutant. The cytokinin triple receptor knockout
mutant ahk2,ahk3,ahk4 also has small cotyledons, but no shape abnormality.
(Scale bar, 1 mm.) (B) The double crf5,crf6 mutant is embryo lethal. Wild-type
and single crf5 and crf6 mutant allele siliques display complete seed set,
whereas the self-set (V) siliques of crf5crf5,CRF6crf6 or CRF5crf5,crf6crf6
individuals result in 25% aborted seeds. The transgenic addition of CRF5
cDNA complements the embryo lethal phenotype in a crf5crf5,crf6crf6
double mutant background. (C) Developing embryos, shown from a self-
fertilized (V) crf5crf5,CRF6crf6 plant, reveals 25% of the embryos fail to
develop past the early heart stage.










cells vs. crf1,2,5 1.0  0.1 mm2 and 705  96 cells in 10-day-old
seedlings). A triple cytokinin receptor mutant (ahk2,3,4) also
displays reduced cotyledon size that results primarily from
reduced cell expansion (ahk2,3,4 cotyledon size is 1.9 0.2 mm2
and are comprised of 933 21 cells in 10-day-old seedlings). The
lack of cell expansion in the triple receptor mutant cotyledons is
distinct from previous studies that found that the reduced size of
the seventh leaf of the ahk2,3,4mutants was the result of reduced
cell number (28), which likely reflects distinct effects of the ahk
mutations on these two different organs. However, the severely
affected crf triple mutant cotyledons have additional defects not
seen in the cytokinin receptor knockouts, such as the lack of
normal pigmentation, suggesting that there are aspects of this
phenotype that may be cytokinin independent.
Interestingly, cytokinins have been closely linked to cotyledon
expansion, and this expansion was used as a bioassay to quantify
cytokinin until the advent of MS-based methods. The CRFs may
mediate the effect of cytokinin on cotyledon cell expansion. In
addition to cotyledons, the crf mutants also occasionally affect
juvenile leaves, but otherwise do not have any other obvious
effect on morphology or development, except for the embryo-
lethal phenotype of the crf5, crf6 double mutant discussed below.
In contrast to other crf mutant combinations tested, all
combinations of independent alleles of both crf5 and crf6 re-
sulted in embryo lethality that was fully penetrant (Fig. 3B; data
not shown). In self-fertilized crf5–1crf5–1 crf6–1CRF6, crf5–
2crf5–2 crf6–1CRF6, or crf5–1CRF5 crf6–2crf6–2 plants,
25% of the seeds are absent from the silique (Fig. 3B).
Approximately 25% of the embryos in these siliques never
progress beyond the late globular to early heart stage of devel-
opment (Fig. 3C). However, none of the single crf5 and crf6
mutant alleles display any detectable embryo defects. In addi-
tion, the crf5–1crf5–1 crf6–1crf6–1 embryo lethal phenotype
can be fully complemented by transformation with a genomic
CRF5 fragment (Fig. 3B). These results suggest that the CRF5
and CRF6 genes are redundant and necessary for embryo
development.
Unlike mutants in the Arabidopsis two-component signaling
pathway, we found little effect of crf single, double and triple
mutants in other cytokinin response assays. For example, there
is little or no significant effect of these mutants on the response
of seedlings to cytokinin in root elongation (see Fig. 9, which is
published as supporting information on the PNAS web site), and
only very minor effects on in vitro shoot initiation assays (see Fig.
10, which is published as supporting information on the PNAS
web site). Furthermore, the morphology of crf mutant seedlings
grown on cytokinin did not differ substantial from the wild type
(data not shown).
The CRFs Mediate Gene Expression in Response to Cytokinin Together
with the Type-B ARRs.Because the CRFs are predicted to function
in the regulation of gene expression, we examined the response
of the transcriptome to cytokinin in the crf mutants. Wild-type
and crf mutant seedlings were treated with cytokinin for 1 h and
gene expression examined in triplicate by using a 29,000 element
Arabidopsis oligonucleotide microarray (Fig. 4A; see Table 4 and
Fig. 11, which are published as supporting information on the
PNAS web site). Strikingly, of 169 genes whose transcript level
was altered by cytokinin in wild-type seedlings, 93 (55%) exhib-
ited a 2-fold or greater decrease in their responsiveness in the
crf1,2,5 mutant, and 81 (48%) in the crf2,3,6 mutant (Fig. 4B).
This indicates that CRF genes regulate a significant portion of
the early transcriptional response to cytokinin. The effect of the
crf triple mutants on several of these genes was verified by using
quantitative PCR (Table 1).
Comparison of the cytokinin response in a type-B ARR
double mutant and the crf mutants revealed substantial overlap
among the genes regulated by these two divergent families of
transcription factors. In the arr1,12, mutant, 111 genes (66%)
exhibited a 2-fold or greater decrease in their cytokinin respon-
siveness as compared to wild type, with 68% of those affected in
arr1,12 similarly affected in the crf1,2,5 mutant and 60% in the
crf2,3,6 mutant (Fig. 4B). Thus, the CRF and type-B ARR genes
regulate an overlapping set of cytokinin-response genes. How-
Table 1. Real-time PCR confirmation of cytokinin-regulated microarray results
Gene name At number
Wild type  vs.  BA crf1,2,5  vs.  BA crf2,3,6  vs.  BA
Microarray RT-PCR Microarray RT-PCR Microarray RT-PCR
Zinc Finger B-box At1g68520 3.1 2.8  0.3 1.0 1.3  0.1 1.1 1.1  0.1
NAM AtNAC6 At4g27410 2.7 2.7  0.2 1.3 0.7  0.1 1.4 1.0  0.1
Speckled POZ At3g48360 3.5 2.7  0.3 1.1 0.8  0.1 0.9 1.0  0.5
Senescene Assoc. P. At1g53885 3.9 2.7  0.3 1.3 1.7  0.1 2.0 1.5  0.3
ARR5 At3g48100 7.3 14.3  0.4 3.2 26.6  1.1 5.0 25.4  0.9
ARR7 At1g19050 3.6 9.5  0.3 5.7 15.1  0.6 5.5 12.1  0.4
Four genes regulated by cytokinin in wild type, but not in CRF mutants, were examined by using real-time PCR, as well as two type-A
ARR genes and show similar trends to the microarrays in Fig. 4A.
Fig. 4. CRFs act in parallel with type-B ARRs to mediate cytokinin regulated
gene expression. (A) Wild-type, arr1,12, crf1,2,5, and crf2,3,6 seedlings were
treated with either 10 M BA or a DMSO control for 1 h and gene expression
analyzed by using a microarray. Genes that displayed a 2-fold change in
response to cytokinin in the wild type are shown. (B) Venn diagram of the 135
cytokinin-regulated genes affected by the arr1,12, crf1,2,5, andor crf2,3,6
mutations. (C) Model of cytokinin signaling. Both AHPs and CRFs move into the
nucleus in response to cytokinin. Once there, the AHPs phosphorylate the
type-B ARRs, which, together with CRFs, mediate cytokinin-regulated gene
expression. See text for further details.
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ever, not all of these genes are similarly regulated, most notably
the type-A ARRs, which exhibit reduced responsiveness to
cytokinin in the arr1,12mutant, still exhibit a wild type or greater
level of induction in the crf1,2,5 and crf2,3,6 mutants (Table 1;
see Table 4). The differential regulation of the type-A ARRs
may contribute to the difference in cytokinin-dependent phe-
notypes observed in the crf and type-B arr mutants.
Model for Cytokinin Response Pathway. These data are consistent
with a model for cytokinin function illustrated in Fig. 4C.
Cytokinin binding to the AHKs initiates a phosphorelay that
results in the phosphorylation of the AHPs. The phosphorylated
AHPs move into the nucleus to activate the type-B ARRs, which
then increase the transcription of a subset of the CRFs. In
parallel, the phosphorylated AHPs induce CRF proteins to
accumulate in the nucleus. Thus, the relocalization of the CRF
proteins defines a branch point in the cytokinin two-component
signal transduction pathway. The activated CRFs, together with
the activated type-B ARRs, mediate cytokinin-regulated gene
expression, affecting an overlapping set of gene targets. In
addition to mediating a portion of the cytokinin response
initiated at the AHK receptors, the CRFs may also play a role
in other signaling or developmental pathways, based on the
difference in phenotypes associated with the crf loss-of-function
mutations compared to those of the cytokinin receptor mutants
(29, 30). In particular, the cytokinin receptor triple mutant is a
viable plant that is distinct from the embryo lethal phenotype of
the crf5,crf6 double mutant. Thus, CRFs are likely to receive
input either from other cytokinin receptors, or from non-
cytokinin-dependent signaling sources.
Materials and Methods
Plant Materials and Treatments. Seedlings were grown under
standard growth conditions as described (13), except for mi-
croarray experiments which were grown as described (23).
Mutant lines are described in detail (see Supporting Text, which
is published as supporting information on the PNAS web site).
Cytokinin treatments were 1 M N6-benzyladenine (BA) for
various times for Northern analysis, 2 M BA for 10 min for
protoplast experiments, and 10 M for 1 h in microarray and
real-time PCR experiments (14-day-old plants). Cycloheximide
was used at 50 M as 1h pretreatments. Stable transformation
of Arabidopsis was performed by floral dip method (31). Arabi-
dopsis leaf mesophyll protoplasts were isolated and transformed
by electroporation as previously described (32) with minor
modifications as detailed (see Supporting Text). Plasmids used
for transformations are described (see Supporting Text).
Microscopy. Epiflorescent microscopy with Hoechst dye 33342 (1
ngml1) and an UV source were used to observe cells and
identify nuclei. A GFP filter that blocks chlorophyll f luorescence
and Hoechst dye 33342 fluorescence was used to examine
localization of GFP fusion proteins. Further details of the
microscopy are presented in Supporting Text.
Microarray Analysis.Microarray analyses were conducted by using
the 29,000-element Arabidopsis oligonucleotide microarrays
(http:ag.arizona.edumicroarray). Genes in these analyses
were considered cytokinin regulated if they were found to be
significant by a Welch’s t test with an adjusted Bonferroni
correction after samplecolumn normalization (TIGRMeV v3.1
available at www.tm4.org) and had a mean fold change 2 or 
2. Further details of the microarray analysis are given in
Supporting Text.
Real-Time PCR. Real-time PCR was carried out (see Supporting
Text). At least two biological and two sample replicates were
performed for each treatment. Ct values were generated by
subtracting blanks and the baseline average over cycles 1–10 with
a 10 SD over the cycle range for each sample. Samples with
melt curves that did not have a single distinct peak were excluded
from further analysis. Fold-change of samples was calculated
after normalization to -tubulin Ct values from each sample.
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